NCT07789041 Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge
| NCT ID | NCT07789041 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Endeavor Health |
| Condition | BPH (Benign Prostatic Hyperplasia) |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-08-12 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-08-12 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Randomized, single-blinded investigational study to assess the safety of PuraStat following the Aquablation procedure
Eligibility Criteria
Inclusion Criteria: 1. Subject must be undergoing Aquablation 2. Subject is willing to comply with protocol requirements Exclusion Criteria: 1. Any significant medical condition which, in the attending physician's opinion, may interfere with the patient's optimal procedure 2. Known or suspected systemic or severe infection 3. Patient unable to give consent
Contact & Investigator
Alexander P Glaser, MD
STUDY DIRECTOR
Endeavor Health
Frequently Asked Questions
Who can join the NCT07789041 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying BPH (Benign Prostatic Hyperplasia). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07789041 currently recruiting?
Yes, NCT07789041 is actively recruiting participants. Contact the research team at PTalaty@northshore.org for enrollment information.
Where is the NCT07789041 trial being conducted?
This trial is being conducted at Glenview, United States.
Who is sponsoring the NCT07789041 clinical trial?
NCT07789041 is sponsored by Endeavor Health. The principal investigator is Alexander P Glaser, MD at Endeavor Health. The trial plans to enroll 50 participants.